News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medifocus Announces Institutional Review Board (IRB) Approval for Second USA Site for Its Phase III Pivotal Breast Cancer Treatment Study



6/3/2011 9:09:23 AM

Medifocus Inc. (OTC:MDFZF.PK) and (TSXV:MFS) is pleased to announce that the Western Institutional Review Board (WIRB) has granted IRB approval to the Comprehensive Breast Center of Coral Springs Florida, a division of 21st Century Oncology to conduct Medifocus’ Pivotal Phase III Breast Cancer Treatment Study, under the supervision of Dr. Mary Beth Tomaselli, M.D.

Read at BioSpace.com


comments powered by Disqus
Medifocus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES